Top Markets
#1 Derive Derive +33.58%
#2 Cross Cross +17.15%
#3 The Bitcoin Bull The Bitcoin Bull +14.40%
#4 Palladium Network Palladium Network +12.35%
#5 Geodnet Geodnet +10.37%
#6 Gama Token Gama Token +9.18%
#7 Audiera Audiera +9.15%
#8 Biconomy Biconomy +8.21%
#9 Velvet Velvet +7.83%
#10 Humanity Humanity +7.73%
Coin of the day
Derive Derive
설정
언어
한국어
통화
USD
테마
Gujarat Terce Laboratories Limited Gujarat Terce Laboratories Limited

Gujarat Terce Laboratories Limited

GUJTERC
주식 순위 #35875
Gujarat Terce Laboratories Ltd. operates as a pharmaceutical enterprise,... Gujarat Terce Laboratories Ltd. operates as a pharmaceutical enterprise, focusing on the production and distribution of various medicinal items. Its comprehensive product range addresses diverse therapeutic areas such as anti-fungal, anti-malarial, and antibiotic treatments, in addition to ayurvedic, cardiovascular, gastrointestinal, gynecological, and respiratory care. The company also offers nutraceuticals, pain relief solutions, and other specialized pharmaceutical products. Mr. N.P. Prajapati founded the company on March 28, 1985, and it is presently based in Ahmedabad, India.
주가
$0.42708845
마지막 동기화: 2026-08-14
시가총액
$3.33M
변동 (1일)
4.48%
변동 (1년)
-9.84%
국가
IN
거래 Gujarat Terce Laboratories Limited (GUJTERC)

카테고리

Healthcare
Gujarat Terce Laboratories Limited (GUJTERC)의 배당 수익률 기록
Gujarat Terce Laboratories Limited (주식 심볼: GUJTERC)의 배당 수익률 (TTM)은 2026 기준으로 0입니다.
지난 5년 평균 배당 수익률: 0.00%
Gujarat Terce Laboratories Limited (GUJTERC)의 배당 수익률 기록: 2026 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 수익률 (TTM)
회사 배당 수익률 국가
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.58%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
0.00%
US